cancer breakthrough pain
Pain · 2007–2017
5decisions
2medicines
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| fentanyl citrate Initial treatment for dose titration of cancer patients with breakthrough pain (BTP) who are already receiving maintenance opioid therapy for chronic pain. | Jul 2017 | Recommended with restriction | input received |
| fentanyl citrate Treatment of breakthrough cancer pain in patients receiving opioids for persistent pain who are unable to tolerate further escalation of short-acting opioids… | Jul 2015 | Recommended with restriction | unclear |
| fentanyl Management of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy and are unable to tolerate further escalation of… | Mar 2014 | Not recommended | unclear |
| fentanyl Management of breakthrough pain in patients with cancer who are already receiving maintenance opioid therapy for chronic pain and are unable to tolerate… | Mar 2014 | Not recommended | unclear |
| fentanyl citrate Treatment of breakthrough pain in palliative care patients with cancer who are receiving opioids for their persistent cancer pain and where further escalation… | Nov 2007 | Recommended with restriction | no section in document |
What the PBS pays
$15M in government benefit over 2024–25, across 322,106 services.
This is spend on the medicines considered for this condition, not spend on the disease. A medicine used for several conditions is counted in full under each, so figures across conditions add to more than national PBS expenditure.
| Medicine | Government benefit |
|---|---|
| fentanyl | $7.7M |
| fentanyl citrate | $7.7M |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 4 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.